| ASSESSMENT | • clinical interview to identify the presence of: marked pessimism, marked psychomotor agitation, refusal of self-care and of the rehabilitation path, poor perceived social-family support • investigation of disease awareness, motivation for treatment and home-based care • if clinical conditions allow, the following screening tests can be used: • for depression and anxiety: hospital anxiety and depression scale (HADS-A),34 depression questionnaire (QD-R),35 generalised anxiety disorder (GAD-7)36 and patient health questionnaire (PHQ-9)37 • for general cognitive decline (patients aged ≥ 75 years): mini mental state examination (MMSE)38 • for mild cognitive impairment in patients aged <75 years with MMSE in normal range but clinical/qualitative indication of cognitive difficulties: Montreal cognitive assessment (MoCA)39 |
| INTERVENTION | • interview of psychological support; relaxation techniques; sleep hygiene; indications to the team and caregiver regarding relational strategies to encourage patient involvement and participation in the care path • involvement of community welfare services in the case of social issues • proposal of environmental strategies to the team and caregiver aimed at improving awareness, managing the disease and reducing eventual cognitive deficits • psycho-educational interventions (on stress management, smoking cessation, eating behaviour) |
| ASSESSMENT | • clinical interview to identify the presence of: marked pessimism, marked psychomotor agitation, refusal of self-care and of the rehabilitation path, poor perceived social-family support • investigation of disease awareness, motivation for treatment and home-based care • if clinical conditions allow, the following screening tests can be used: • for depression and anxiety: hospital anxiety and depression scale (HADS-A),34 depression questionnaire (QD-R),35 generalised anxiety disorder (GAD-7)36 and patient health questionnaire (PHQ-9)37 • for general cognitive decline (patients aged ≥ 75 years): mini mental state examination (MMSE)38 • for mild cognitive impairment in patients aged <75 years with MMSE in normal range but clinical/qualitative indication of cognitive difficulties: Montreal cognitive assessment (MoCA)39 |
| INTERVENTION | • interview of psychological support; relaxation techniques; sleep hygiene; indications to the team and caregiver regarding relational strategies to encourage patient involvement and participation in the care path • involvement of community welfare services in the case of social issues • proposal of environmental strategies to the team and caregiver aimed at improving awareness, managing the disease and reducing eventual cognitive deficits • psycho-educational interventions (on stress management, smoking cessation, eating behaviour) |
| ASSESSMENT | • clinical interview to identify the presence of: marked pessimism, marked psychomotor agitation, refusal of self-care and of the rehabilitation path, poor perceived social-family support • investigation of disease awareness, motivation for treatment and home-based care • if clinical conditions allow, the following screening tests can be used: • for depression and anxiety: hospital anxiety and depression scale (HADS-A),34 depression questionnaire (QD-R),35 generalised anxiety disorder (GAD-7)36 and patient health questionnaire (PHQ-9)37 • for general cognitive decline (patients aged ≥ 75 years): mini mental state examination (MMSE)38 • for mild cognitive impairment in patients aged <75 years with MMSE in normal range but clinical/qualitative indication of cognitive difficulties: Montreal cognitive assessment (MoCA)39 |
| INTERVENTION | • interview of psychological support; relaxation techniques; sleep hygiene; indications to the team and caregiver regarding relational strategies to encourage patient involvement and participation in the care path • involvement of community welfare services in the case of social issues • proposal of environmental strategies to the team and caregiver aimed at improving awareness, managing the disease and reducing eventual cognitive deficits • psycho-educational interventions (on stress management, smoking cessation, eating behaviour) |
| ASSESSMENT | • clinical interview to identify the presence of: marked pessimism, marked psychomotor agitation, refusal of self-care and of the rehabilitation path, poor perceived social-family support • investigation of disease awareness, motivation for treatment and home-based care • if clinical conditions allow, the following screening tests can be used: • for depression and anxiety: hospital anxiety and depression scale (HADS-A),34 depression questionnaire (QD-R),35 generalised anxiety disorder (GAD-7)36 and patient health questionnaire (PHQ-9)37 • for general cognitive decline (patients aged ≥ 75 years): mini mental state examination (MMSE)38 • for mild cognitive impairment in patients aged <75 years with MMSE in normal range but clinical/qualitative indication of cognitive difficulties: Montreal cognitive assessment (MoCA)39 |
| INTERVENTION | • interview of psychological support; relaxation techniques; sleep hygiene; indications to the team and caregiver regarding relational strategies to encourage patient involvement and participation in the care path • involvement of community welfare services in the case of social issues • proposal of environmental strategies to the team and caregiver aimed at improving awareness, managing the disease and reducing eventual cognitive deficits • psycho-educational interventions (on stress management, smoking cessation, eating behaviour) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
